Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M. Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J. Gerry Coghlan, James Lordan, Colin Church, Luke S. Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen J. Wort, David G. Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W. Morrell, Martin R. Wilkins, […]
Jing Li, Xin He, Feng Liu, Kinglong Zheng, Jing JiangFirst Affiliated Hospital of Xi’an Jiaotong University. Fourth Military Medical University.China Journal of Cardiovascular PharmacologyJ Cardiovasc Pharmacol 2024; 83:73-85DOI: 10.1097/FJC.0000000000001505 AbstractPulmonary arterial hypertension (PAH) is characterized by pulmonary arterial endothelial cell (PAEC) dysfunction and pulmonary arterial smooth muscle cell (PASMC) activation. For decades, the therapies for PAH
Manivannan Yegambaram, Xutong Sun, Alejandro Garcia Flores, Qing Lu, Jamie Soto, Jaime Richards, Saurabh Aggarwal, Ting Wang, Haiwei Gu, Jeffrey R. Fineman, Stephen M. BlackFlorida International University. University of California San Francisco.United States International Journal of Molecular SciencesInt J Mol Sci 2023; 24:DOI: 10.3390/ijms242417533 AbstractThe disruption of mitochondrial dynamics has been identified in cardiovascular diseases, including
Yi‑Chia Wu, Wei‑Ting Wang, Ming‑Chun Yang, Yu‑Tsun Su, Jwu‑Lai Yeh, Jong‑Hau Hsu, Jiunn‑Ren WuKaohsiung Medical University Hospital and Kaohsiung Medical University. Kaohsiung Municipal Ta-Tung Hospital. E-Da Hospital and I-Shou University.Taiwan Biological ResearchBiol Res 2023; DOI: 10.1186/s40659-023-00480-z AbstractBackground: Abnormal remodeling of the pulmonary vasculature, characterized by the proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) along
Yoogyeong Oh, Kyungtae Park, Sungwon Jung, Moonhyun Choi, Taihyun Kim, Yoojin Kim, Yoojin Lee, Jae Young Choi, Yang-Hee Kim, Se Yong Jung, Jinkee HongYonsei University College of Medicine. University of Southampton.Republic of Korea and United Kingdom SmallSmall 2023; DOI: 10.1002/smll.202308936 AbstractPulmonary arterial hypertension (PAH) is a severe medical condition characterized by elevated blood pressure in the
Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment Read More »
A. Dushani C. U. Ranasinghe, Maggie Holohan, Kalyn M. Borger, Deborah L. Donahue, Rafael D. Kuc, Martin Gerig, Andrew Kim, Victoria A. Ploplis, Francis J. Castellino, Margaret A. SchwarzHarper Cancer Research Institute and University of Notre Dame.United States Circulation ResearchCirc Res 2023; 133: 704-719DOI: 10.1161/CIRCRESAHA.123.322740 AbstractBackground: Epigenetic regulation of vascular remodeling in pulmonary hypertension (PH) is poorly
Sarasa Isobe, Ramesh V. Nair, Helen Y. Kang, Lingli Wang, Jan-Renier Moonen, Tsutomu Shinohara, Aiqin Cao1, Shalina Taylor, Shoichiro Otsuki, David P. Marciano, Rebecca L. Harper, Mir S. Adil, Chongyang Zhang, Mauro Lago-Docampo, Jakob Körbelin, Jesse M. Engreitz, Michael P. Snyder, Marlene RabinovitchLucile Packard Children’s Hospital and Stanford University School of Medicine. University Medical Center
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension Read More »
Manivannan Yegambaram, Xutong Sun, Qing Lu, Yan Jin, Wojciech Ornatowski, Jamie Soto, Saurabh Aggarwal, Ting Wang, Kim Tieu, Haiwei Gu, Jeffrey R. Fineman, Stephen M. BlackFlorida International University. University of Arizona. University of California San Francisco.United States Free Radical Biology and MedicineFree Radic Biol Med 2023; DOI: 10.1016/j.freeradbiomed.2023.11.008 AbstractObjective: Pulmonary hypertension (PH) is a progressive disease with
Albert L. HymanTulane University School of Medicine.United States Annual Review of MedicineAnnu Rev Med 1966; 17: 431-446DOI: 10.1146/annurev.me.17.020166.002243 AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionReview Articles Concerning Pulmonary Vascular Disease Age Focus: No Age-Related Focus Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article Access Free
The pulmonary veins Read More »
Albert L. Hyman, G. SanchezTulane University School of Medicine.United States Journal of Laboratory and Clinical MedicineJ Lab Clin Med 1969; 73: 476-485DOI: Not Available AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionAnimal Models of Pulmonary Vascular Disease and Therapy Age Focus: No Age-Related Focus Fresh or Filed Publication: Filed (PHiled).
